Evaluation of eIF4E expression in an osteosarcoma-specific tissue microarray

Tanasa S. Osborne, Ling Ren, John H. Healey, Lauren Q. Shapiro, Alexander Ja-Ho Chou, Richard G. Gorlick, Stephen M. Hewitt, Chand Khanna

Research output: Contribution to journalArticle

21 Citations (Scopus)

Abstract

The ability to define osteosarcoma (OS) patients at greatest risk for metastatic progression and nonresponsiveness to conventional therapy is currently not possible. Such biomarkers are needed to predict overall prognosis, probability of metastases at diagnosis, and response to chemotherapy. The tissue microarray (TMA) serves as a powerful tool for detecting and validating protein biomarkers across a variety of patients. We constructed a novel outcome-linked TMA to add to and address shortcomings of currently available OS tissue resources. To test the use of our TMA, we surveyed the expression of eukaryotic initiation factor 4E (eIF4E) in OS patients using immunohistochemistry. Aberrant regulation of translation initiation is a feature of many cancers. eIF4E is central to initiation of protein synthesis. Its expression and activity have been implicated in tumor formation and potentially malignant and/or metastatic progression in some carcinomas. We found that eIF4E was uniformly expressed in OS patient samples. No association was found between eIF4E and outcome in OS patients. This novel OS TMA provided a facile mechanism to assess the role of a relevant protein biomarker in OS.

Original languageEnglish (US)
Pages (from-to)524-528
Number of pages5
JournalJournal of Pediatric Hematology/Oncology
Volume33
Issue number7
DOIs
StatePublished - Oct 2011

Fingerprint

Eukaryotic Initiation Factor-4E
Osteosarcoma
Biomarkers
Proteins
Neoplasms
Immunohistochemistry
Neoplasm Metastasis
Carcinoma
Drug Therapy

Keywords

  • eIF4E
  • immunohistochemistry
  • osteosarcoma
  • tissue microarray

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Oncology
  • Hematology

Cite this

Evaluation of eIF4E expression in an osteosarcoma-specific tissue microarray. / Osborne, Tanasa S.; Ren, Ling; Healey, John H.; Shapiro, Lauren Q.; Chou, Alexander Ja-Ho; Gorlick, Richard G.; Hewitt, Stephen M.; Khanna, Chand.

In: Journal of Pediatric Hematology/Oncology, Vol. 33, No. 7, 10.2011, p. 524-528.

Research output: Contribution to journalArticle

Osborne, TS, Ren, L, Healey, JH, Shapiro, LQ, Chou, AJ-H, Gorlick, RG, Hewitt, SM & Khanna, C 2011, 'Evaluation of eIF4E expression in an osteosarcoma-specific tissue microarray', Journal of Pediatric Hematology/Oncology, vol. 33, no. 7, pp. 524-528. https://doi.org/10.1097/MPH.0b013e318223d0c1
Osborne, Tanasa S. ; Ren, Ling ; Healey, John H. ; Shapiro, Lauren Q. ; Chou, Alexander Ja-Ho ; Gorlick, Richard G. ; Hewitt, Stephen M. ; Khanna, Chand. / Evaluation of eIF4E expression in an osteosarcoma-specific tissue microarray. In: Journal of Pediatric Hematology/Oncology. 2011 ; Vol. 33, No. 7. pp. 524-528.
@article{633a0ed745514f28a8fc158c1f11a8d9,
title = "Evaluation of eIF4E expression in an osteosarcoma-specific tissue microarray",
abstract = "The ability to define osteosarcoma (OS) patients at greatest risk for metastatic progression and nonresponsiveness to conventional therapy is currently not possible. Such biomarkers are needed to predict overall prognosis, probability of metastases at diagnosis, and response to chemotherapy. The tissue microarray (TMA) serves as a powerful tool for detecting and validating protein biomarkers across a variety of patients. We constructed a novel outcome-linked TMA to add to and address shortcomings of currently available OS tissue resources. To test the use of our TMA, we surveyed the expression of eukaryotic initiation factor 4E (eIF4E) in OS patients using immunohistochemistry. Aberrant regulation of translation initiation is a feature of many cancers. eIF4E is central to initiation of protein synthesis. Its expression and activity have been implicated in tumor formation and potentially malignant and/or metastatic progression in some carcinomas. We found that eIF4E was uniformly expressed in OS patient samples. No association was found between eIF4E and outcome in OS patients. This novel OS TMA provided a facile mechanism to assess the role of a relevant protein biomarker in OS.",
keywords = "eIF4E, immunohistochemistry, osteosarcoma, tissue microarray",
author = "Osborne, {Tanasa S.} and Ling Ren and Healey, {John H.} and Shapiro, {Lauren Q.} and Chou, {Alexander Ja-Ho} and Gorlick, {Richard G.} and Hewitt, {Stephen M.} and Chand Khanna",
year = "2011",
month = "10",
doi = "10.1097/MPH.0b013e318223d0c1",
language = "English (US)",
volume = "33",
pages = "524--528",
journal = "Journal of Pediatric Hematology/Oncology",
issn = "1077-4114",
publisher = "Lippincott Williams and Wilkins",
number = "7",

}

TY - JOUR

T1 - Evaluation of eIF4E expression in an osteosarcoma-specific tissue microarray

AU - Osborne, Tanasa S.

AU - Ren, Ling

AU - Healey, John H.

AU - Shapiro, Lauren Q.

AU - Chou, Alexander Ja-Ho

AU - Gorlick, Richard G.

AU - Hewitt, Stephen M.

AU - Khanna, Chand

PY - 2011/10

Y1 - 2011/10

N2 - The ability to define osteosarcoma (OS) patients at greatest risk for metastatic progression and nonresponsiveness to conventional therapy is currently not possible. Such biomarkers are needed to predict overall prognosis, probability of metastases at diagnosis, and response to chemotherapy. The tissue microarray (TMA) serves as a powerful tool for detecting and validating protein biomarkers across a variety of patients. We constructed a novel outcome-linked TMA to add to and address shortcomings of currently available OS tissue resources. To test the use of our TMA, we surveyed the expression of eukaryotic initiation factor 4E (eIF4E) in OS patients using immunohistochemistry. Aberrant regulation of translation initiation is a feature of many cancers. eIF4E is central to initiation of protein synthesis. Its expression and activity have been implicated in tumor formation and potentially malignant and/or metastatic progression in some carcinomas. We found that eIF4E was uniformly expressed in OS patient samples. No association was found between eIF4E and outcome in OS patients. This novel OS TMA provided a facile mechanism to assess the role of a relevant protein biomarker in OS.

AB - The ability to define osteosarcoma (OS) patients at greatest risk for metastatic progression and nonresponsiveness to conventional therapy is currently not possible. Such biomarkers are needed to predict overall prognosis, probability of metastases at diagnosis, and response to chemotherapy. The tissue microarray (TMA) serves as a powerful tool for detecting and validating protein biomarkers across a variety of patients. We constructed a novel outcome-linked TMA to add to and address shortcomings of currently available OS tissue resources. To test the use of our TMA, we surveyed the expression of eukaryotic initiation factor 4E (eIF4E) in OS patients using immunohistochemistry. Aberrant regulation of translation initiation is a feature of many cancers. eIF4E is central to initiation of protein synthesis. Its expression and activity have been implicated in tumor formation and potentially malignant and/or metastatic progression in some carcinomas. We found that eIF4E was uniformly expressed in OS patient samples. No association was found between eIF4E and outcome in OS patients. This novel OS TMA provided a facile mechanism to assess the role of a relevant protein biomarker in OS.

KW - eIF4E

KW - immunohistochemistry

KW - osteosarcoma

KW - tissue microarray

UR - http://www.scopus.com/inward/record.url?scp=80053321287&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80053321287&partnerID=8YFLogxK

U2 - 10.1097/MPH.0b013e318223d0c1

DO - 10.1097/MPH.0b013e318223d0c1

M3 - Article

C2 - 21941146

AN - SCOPUS:80053321287

VL - 33

SP - 524

EP - 528

JO - Journal of Pediatric Hematology/Oncology

JF - Journal of Pediatric Hematology/Oncology

SN - 1077-4114

IS - 7

ER -